Tag
Bal Pharma Limited
4 articles
Bal Pharma, Tai Industries, MM Rubber Q2 Results
Bal Pharma Limited published unaudited Q2 FY2026-27 financial results in newspapers per SEBI LODR regulations.
Tai Industries Limited reported Q2 net profit of ₹95.75 lakh, a 171% increase from ₹35.31
Bal Pharma Reports Zero Preferential Issue Proceeds Utilization
Bal Pharma Limited filed a regulatory statement confirming no utilization of ₹2.1 crore raised through a preferential warrant issue for the quarter ended September 30, 2026.
The funds were raised on S
Bal Pharma Q2 Net Profit Rises 95% YoY
Board approved Q2 FY27 unaudited standalone and consolidated financial results with unmodified auditor review.
Standalone Q2 net profit increased to ₹152.71 lakh from ₹78.17 lakh YoY, with revenue up
Bal Pharma Q2 FY27 Net Profit Rises 95% YoY
Bal Pharma reported unaudited Q2 FY27 standalone revenue of ₹897.2 lakhs and net profit of ₹152.71 lakhs, a 95% YoY increase.
The company raised ₹210 lakhs through a preferential warrant issue in Sept